The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Open accessAbstract
For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biology of the prion diseases. Recently, owing largely to the advent of new disease models, this hypothesis has gained experimental momentum. In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid. Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease. Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin. However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function. As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The recent discovery that specific misfolded and aggregated proteins can propagate and spread in a prion-like fashion has sparked considerable interest (67).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In Parkinson’s disease and Lewy body disease, α-synuclein aggregates initially spread through the brainstem and olfactory bulb followed by limbic structures, and only thence to the neocortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In each of these cases, the aggregates initially deposit at the ventral base of the forebrain and midbrain, and then extend rostrally and dorsally to the cortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“While still a contentious topic [46], there is now substantial evidence that also supports the idea that propagation of pathological tau species occurs between cells [47–50].”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [50]
In the citing paper
“As aforementioned, the neuropathological lesions of not only AD but also PD/DLB and amyotrophic lateral sclerosis (ALS) are known to spread through the brain in a rather specific pattern, which also serves as a basis for the neuropathological staging of disease severity [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“Importantly, the spatiotemporal spread of αSyn lesions in PD/DLB is nearly inverted to the spread of Aβ and tau pathology as observed in AD [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“pathological neurofibrillary Tau aggregates show a pattern of accumulation that starts in the entorhinal cortex and spreads through connected pathways to cortical areas (Jucker and Walker, 2013)”
From Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease (2020) · cites this paper as Jucker and Walker, 2013
In the citing paper
“It has been suggested that alpha-synuclein could act like a prion protein during PD pathogenesis.In this theory pathologic, misfolded alpha-synuclein is an 'infectious' protein spreading pathology by forming a template that seeds misfolding for nearby alpha-synuclein protein, turning the previously healthy protein into a pathogenic protein (Jucker and Walker, 2013;Visanji et al., 2013).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Jucker and Walker, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Molecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Cited by
Sorted by citations
Items 801–900 of 1,000
The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer’s Disease
Wang, Y. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220417005115 · Cited by 21
Yuan, Q., Wu, Y., Wang, G., Zhou, X., Dong, X., Lou, Z., Li, S., & Wang, D. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01031-3 · Cited by 21
Pini, L., Lista, S., Griffa, A., Allali, G., & Imbimbo, B. P. (2024) · Brain Communications · doi:10.1093/braincomms/fcae460 · Cited by 22
Takai, E., Ohashi, G., Yoshida, T., Sörgjerd, K. M., Zako, T., Maeda, M., Kitano, K., & Shiraki, K. (2014) · Applied Physics Letters · doi:10.1063/1.4861842 · Cited by 21
Targeting prion propagation using peptide constructs with signal sequence motifs
Söderberg, K. L., Guterstam, P., Langel, Ü., & Gräslund, A. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.10.009 · Cited by 21
Hijacking PrPc-dependent signal transduction: when prions impair Aβ clearance
Hernandez-Rapp, J., Martin‐Lannerée, S., Hirsch, T. Z., Launay, J., & Mouillet‐Richard, S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00025 · Cited by 24
Blood-Based Biomarkers of Alzheimers Disease: Diagnostic Algorithms and New Technologies
Carmona, P., Molina, M., & Tolédano, A. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151116130301 · Cited by 21
Molecular mechanisms of chronic traumatic encephalopathy
van den Bedem, H., & Ellen Kuhl, A. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.02.003 · Cited by 21
Wang, F., Wang, X., Abskharon, R. N. N., & Ma, J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0534-0 · Cited by 21
Phenotypic diversity in ALS and the role of poly-conformational protein misfolding
Ayers, J. I., & Borchelt, D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02222-x · Cited by 21
Parallel and antiparallel peptide double β‐helices controlled by metal‐induced folding and assembly
Sawada, T., Iwasaki, W., Yamagami, M., & Fujita, M. (2021) · Natural Sciences · doi:10.1002/ntls.10008 · Cited by 21
Raj, A. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0905 · Cited by 21
Targeting disorders in unstructured and structured proteins in various diseases
Choudhary, S., Lopus, M., & Hosur, R. V. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106742 · Cited by 21
Juan, S. M. A., Daglas, M., & Adlard, P. A. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2021.0241 · Cited by 21
Pal, S., & Melnik, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-11242-4 · Cited by 22
Popelová, A., Pražienková, V., Neprašová, B., Kasperová, B. J., Hrubá, L., Holubová, M., Zemenová, J., Blum, D. L., Železná, B., Galas, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171041 · Cited by 22
Direct Evidence for Self-Propagation of Different Amyloid-β Fibril Conformations
Spirig, T., Ovchinnikova, O. Y., Vagt, T., & Glockshuber, R. (2014) · Neurodegenerative Diseases · doi:10.1159/000363623 · Cited by 20
Spatial Propagation of Protein Polymerization
Cohen, S. I. A., Rajah, L., Yoon, C. H., Buell, A. K., White, D. A., Sperling, R. A., Vendruscolo, M., Terentjev, E. M., Dobson, C. M., Weitz, D. A., et al. (2014) · Physical Review Letters · doi:10.1103/physrevlett.112.098101 · Cited by 20
Helboe, L., Rosenqvist, N., Volbracht, C., Pedersen, L. Ø., Pedersen, J. T., Christensen, S., Egebjerg, J., Christoffersen, C. T., Bang‐Andersen, B., Beach, T. G., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220125 · Cited by 20
Brain structure and structural basis of neurodegenerative diseases
Yang, J., Sui, S., & Liu, Z. (2022) · Biophysics Reports · doi:10.52601/bpr.2022.220013 · Cited by 20
Modulating amyloids’ formation path with sound energy
Kozell, A., Eliaz, D., Solomonov, A. V., Benyamin, D., Shmul, G., Brookstein, O., Rosenhek‐Goldian, I., Raviv, U., & Shimanovich, U. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212849120 · Cited by 20
Ahanger, I. A., Ashraf, G. M., Sharma, A., & Islam, A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230306085937 · Cited by 20
Wang, R., Lu, K. P., & Zhou, X. Z. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15909 · Cited by 20
Vo, A., Tremblay, C., Rahayel, S., Shafiei, G., Hansen, J. Y., Yau, Y. H. C., Mišić, B., & Dagher, A. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103523 · Cited by 20
Neurotropic virus infection and neurodegenerative diseases: Potential roles of autophagy pathway
Zhao, Y., Xu, K., Shu, F., & Zhang, F. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14548 · Cited by 22
Thomas, E. V., Fenton, W. A., McGrath, J. M., & Horwich, A. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701465114 · Cited by 23
Shi, J., Pei, J., Liu, E., & Zhang, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173871 · Cited by 22
Candelise, N., Schmitz, M., Correia, S., Arora, A. S., Villar‐Piqué, A., Zafar, S., Llorens, F., Cramm, M., & Zerr, I. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1368389 · Cited by 20
DasGupta, D., Mandalaparthy, V., & Jayaram, B. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.25072 · Cited by 24
Li, H., Wang, X., Yu, H., Zhu, J., Jin, H., Wang, A., & Yang, Z. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171030142108 · Cited by 21
Okamura, M., Yamanaka, Y., Shigemoto, M., Kitadani, Y., Kobayashi, Y., Kambe, T., Nagao, M., Kobayashi, I., Okumura, K., & Masuda, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197165 · Cited by 20
Current and future circulating biomarkers for cardiac amyloidosis
Luciani, M., Troncone, L., & del Monte, F. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.38 · Cited by 20
Guttuso, T. J. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109302 · Cited by 20
Clinical implications of extracellular vesicles in neurodegenerative diseases
Vinaiphat, A., & Sze, S. K. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1657407 · Cited by 20
Joseph, C. R. (2020) · Biomedicines · doi:10.3390/biomedicines8070228 · Cited by 20
Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
Wang, P., & Ye, Y. (2021) · Life · doi:10.3390/life11090938 · Cited by 21
Estácio, S. G., Leal, S. S., Cristóvão, J. S., Faísca, P. F. N., & Gomes, C. M. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.11.005 · Cited by 20
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Xia, Z.-D., Ma, R.-X., Wen, J.-F., Zhai, Y.-F., Wang, Y.-Q., Wang, F.-Y., Liu, D., Zhao, X.-L., Sun, B., Jia, P., et al. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-230326 · Cited by 19
van der Meer, F., Jørgensen, J., & Hiligsmann, M. (2024) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2024.2390042 · Cited by 20
Brain Network Dynamics and Multiscale Modeling of Neurodegenerative Disorders: A Review
Shaheen, H., & Melnik, R. (2025) · IEEE Access · doi:10.1109/access.2025.3542634 · Cited by 19
Raj, A., Torok, J., & Ranasinghe, K. G. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102750 · Cited by 20
Nakagawa, Y., & Yamada, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01234-3 · Cited by 20
Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis
Tredici, K. D., & Braak, H. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001098 · Cited by 19
Sollmann, N., Hoffmann, G., Schramm, S., Reichert, M., Petzsche, M. R. H., Strobel, J., Nigris, L., Kloth, C., Roßkopf, J., Börner, C., et al. (2023) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-2119-5574 · Cited by 19
Zhang, X., Zou, L., Tang, L., Xiong, M., Yan, X., Meng, L., Chen, G., Xiong, J., Nie, S., Zhang, Z., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002470 · Cited by 20
Li, Y., Zhou, C., Liu, H., Cai, T., & Fan, H. (2024) · Biomolecules · doi:10.3390/biom14030312 · Cited by 20
Defining the Dynamic Conformational Networks of Cross‐β Peptide Assembly
Smith, J., Liang, C., Tseng, M., Li, N., Li, S., Rha, A. K., Mehta, A. K., & Lynn, D. G. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201500012 · Cited by 19
Victoria, G. S., & Zurzolo, C. (2015) · Virus Research · doi:10.1016/j.virusres.2015.01.019 · Cited by 20
Ruiz-Arlandis, G., Pieri, L., Bousset, L., & Melki, R. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12258 · Cited by 21
What amyloid ligands can tell us about molecular polymorphism and disease
LeVine, H., & Walker, L. C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.019 · Cited by 19
Self-citationNew protein deposition tracers in the pipeline
Jovalekic, A., Koglin, N., Mueller, A., & Stephens, A. W. (2016) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-016-0015-3 · Cited by 19
Wickner, R. B. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.004168 · Cited by 19
Igel‐Egalon, A., Laferrière, F., Moudjou, M., Bohl, J., Mezache, M., Knäpple, T., Herzog, L., Reine, F., Jas-Duval, C., Doumic, M., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0608-y · Cited by 19
Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
Grossmann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094805 · Cited by 20
Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review
Zhang, P., Rasheed, M., Liang, J., Wang, C., Feng, L. P., & Chen, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.819836 · Cited by 19
Transport of cargo from periphery to brain by circulating monocytes
Cintron, A. F., Dalal, N. V., Dooyema, J. M., Betarbet, R. S., & Walker, L. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.047 · Cited by 19
Self-citationSingle cell imaging and quantification of TDP-43 and α-synuclein intercellular propagation
Peled, S., Sade, D., Bram, Y., Porat, Z., Kreiser, T., Mimouni, M., Lichtenstein, A., Segal, D., & Gazit, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-00657-z · Cited by 19
Bede, P. (2017) · Neurology · doi:10.1212/wnl.0000000000004582 · Cited by 19
Advances in Studies on Stroke-Induced Secondary Neurodegeneration (SND) and Its Treatment
Datta, A., Sarmah, D., Kalia, K., Borah, A., Wang, X., Dave, K. R., Yavagal, D. R., & Bhattacharya, P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200416090820 · Cited by 18
Michno, W., Blennow, K., Zetterberg, H., & Brinkmalm, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15466 · Cited by 18
Is Multiple System Atrophy a Prion-like Disorder?
Jellinger, K. A., Wenning, G. K., & Stefanova, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810093 · Cited by 19
Umeda, T., Uekado, R., Shigemori, K., Eguchi, H., & Tomiyama, T. (2022) · Biomedicines · doi:10.3390/biomedicines10020297 · Cited by 18
Sanches, M. N., Knapp, K., Junior, A. B. D. O., Wolynes, P. G., Onuchic, J. N., & Leite, V. B. P. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c08525 · Cited by 18
Vaccines for prion diseases: a realistic goal?
Napper, S., & Schätzl, H. M. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03749-7 · Cited by 18
The Role of Clearance in Neurodegenerative Diseases
Brennan, G. S., Thompson, T., Oliveri, H., Rognes, M. E., & Goriely, A. (2023) · SIAM Journal on Applied Mathematics · doi:10.1137/22m1487801 · Cited by 20
Kakish, J., Allen, K. J. H., Harkness, T. A. A., Krol, E. S., & Lee, J. S. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00209 · Cited by 18
Fernández-Fúnez, P., Sanchez-Garcia, J., & Rincón-Limas, D. E. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.013 · Cited by 18
AGGRESCAN3D: Toward the Prediction of the Aggregation Propensities of Protein Structures
Pujols, J., Peña‐Díaz, S., & Ventura, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7756-7_21 · Cited by 18
Stochastic yield catastrophes and robustness in self-assembly
Gartner, F. M., Graf, I. R., Wilke, P., Geiger, P. M., & Frey, E. (2020) · eLife · doi:10.7554/elife.51020 · Cited by 19
Kaku, H., & Rothstein, T. L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00032 · Cited by 18
Blumenau, S., Foddis, M., Müller, S., Holtgrewe, M., Bentele, K., Berchtold, D., Beule, D., Dirnagl, U., & Sassi, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63183-5 · Cited by 19
Gil, R. S., Cox, D., McAlary, L., Berg, T., Walker, A. K., Yerbury, J. J., Ooi, L., & Ecroyd, H. W. (2020) · Journal of Cell Science · doi:10.1242/jcs.243709 · Cited by 18
Moelgg, K., Jummun, F., & Humpel, C. (2021) · Biomolecules · doi:10.3390/biom11030434 · Cited by 18
Raj, A., & Powell, F. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118008 · Cited by 18
Yoon, H., Kim, B. S., Jeong, J. H., Kim, G. H., Park, H. K., & Chun, M. Y. (2021) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000003662 · Cited by 18
Principles of brain aging: Status and challenges of modeling human molecular changes in mice
Kluever, V., & Fornasiero, E. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101465 · Cited by 18
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000025 · Cited by 18
Wakeman, D. R., Weed, M. R., Perez, S. E., Cline, E. N., Viola, K. L., Wilcox, K. C., Moddrelle, D. S., Nisbett, E. Z., Kurian, A., Bell, A., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12800 · Cited by 18
Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches
Galasko, D. R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00256 · Cited by 19
Úbeda‐Bañón, I., Flores‐Cuadrado, A., Saiz‐Sánchez, D., & Martı́nez-Marcos, A. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00113 · Cited by 19
The release and transmission of amyloid precursor protein via exosomes
Zheng, T., Wu, X., Wei, X., Wang, M., & Zhang, B. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.009 · Cited by 18
Eraña, H. (2019) · Prion · doi:10.1080/19336896.2019.1569451 · Cited by 19
Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
Ferrantelli, F., Chiozzini, C., Leone, P., Manfredi, F., & Federico, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060529 · Cited by 17
Personalised regional modelling predicts tau progression in the human brain
Chaggar, P., Vogel, J. W., Binette, A. P., Thompson, T., Strandberg, O. T., Mattsson, N., Karlsson, L., Stomrud, E., Jbabdi, S., Magon, S., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003241 · Cited by 19
Human Glucose Transporters in Health and Selected Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157392 · Cited by 18
Nakagawa, Y., & Yamada, S. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107455 · Cited by 18
The diverse role of optineurin in pathogenesis of disease
Guo, Q., Wang, J., & Weng, Q. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114157 · Cited by 19
Nguyen, P. H., & Derreumaux, P. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c02836 · Cited by 17
Askari, S., Javadpour, P., Rashidi, F. S., Dargahi, L., Kashfi, K., & Ghasemi, R. (2022) · Life · doi:10.3390/life12091374 · Cited by 17
Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS
Vazquez‐Sanchez, S., Tilkin, B., Gasset-Rosa, F., Zhang, S., Piol, D., McAlonis‐Downes, M., Artates, J. W., Govea-Perez, N., Verresen, Y., Guo, L. E., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00737-5 · Cited by 17
Neurodegenerative disorders: Dysregulation of a carefully maintained balance?
Swart, C., Haylett, W. L., Kinnear, C. J., Johnson, G., Bardien, S., & Loos, B. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.003 · Cited by 19
Amyloids of multiple species: are they helpful in survival?
Upadhyay, A., & Mishra, A. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12399 · Cited by 17
Combining molecular dynamics simulations and experimental analyses in protein misfolding
Wille, H., Dorosh, L., Amidian, S., Schmitt‐Ulms, G., & Stepanova, M. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.10.001 · Cited by 17
Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates
Gosset, P., Maxan, A., Alpaugh, M., Breger, L. S., Dehay, B., Zhu, T., Zhang, L., Qin, C., Cisbani, G., Fortin, N., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104941 · Cited by 17
Prion potentiation after life-long dormancy in mice devoid of PrP
Martin, D., Reine, F., Herzog, L., Igel‐Egalon, A., Aron, N., Michel, C., Moudjou, M., Fichet, G., Quadrio, I., Perret‐Liaudet, A., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab092 · Cited by 18
Zhou, L., & Xu, G. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167457 · Cited by 17
Serpell, L. C. (2014) · Essays in Biochemistry · doi:10.1042/bse0560001 · Cited by 17
The Use of Cerebrospinal Fluid and Neuropathologic Studies in Neuropsychiatry Practice and Research
Kansal, K., & Irwin, D. J. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.02.002 · Cited by 18
Maarouf, C. L., Kokjohn, T. A., Walker, D. G., Whiteside, C. M., Kalback, W. M., Whetzel, A. M., Sue, L. I., Serrano, G. E., Jacobson, S. A., Sabbagh, M. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105784 · Cited by 17
Appocher, C., Klima, R., & Feiguin, F. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu393 · Cited by 17
Metadata
- Authors
- Jucker, M., & Walker, L. C.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- Emory University (US)
- Corresponding author
- Jucker, Mathias
- Walker, Lary C.
- Venue
- Nature
- Published
- 2013-09-04
- Volume
- 501
- Issue
- 7465
- Pages
- 45-51
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3963807
- OpenAlex
- W2034147064
- Cited by
- 1,663
- References
- 126
- Citations by year
- 2026: 82 · 2025: 113 · 2024: 114 · 2023: 111 · 2022: 119 · 2021: 161 · 2020: 140 · 2019: 153 · 2018: 131 · 2017: 166 · 2016: 147 · 2015: 119 · 2014: 101 · 2013: 6
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- National Institutes of Health (P51OD011132)
- National Institute on Aging (R21AG040589)
- National Center for Research Resources (P51RR165, P51RR000165)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- protein aggregation, seeded aggregation, neurodegenerative diseases, prion disease, Alzheimer's disease, Parkinson's disease, Creutzfeldt-Jakob disease, protein misfolding, amyloid, oligomers, proteinopathies, disease models, neurodegeneration therapy
- MeSH terms
- Alzheimer Disease, Amyloid, Animals, Humans, Prions, tau Proteins, Prion Diseases, Neurodegenerative Diseases, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
